The invention concerns novel benzisoselen-azoline and -azine derivatives. These novel derivatives have the following general formula (II): ##STR1## where: R.sup.1 to R.sup.8 and R.sup.10 have various meanings, in particular H, alkyl, etc . . . ; ##STR2## Y.sup.- represents the anion of a pharmaceutically acceptable anion; n=0, 1; m=0, 1, 2; p=1, 2, 3; q=2, 3, 4; r=0, 1; and their pharmaceutically acceptable salts of acids or bases; there being no more than one substituent R.sup.9 in each molecule with general formula II. These novel derivatives can be used in medication.
本发明涉及新型苯并异
硒唑和-嗪衍
生物。这些新的衍
生物具有以下通式(II):##STR1## 其中:R.sup.1到R.sup.8和R.sup.10具有各种含义,特别是H,烷基等; ##STR3## Y.sup.-表示药学上可接受的阴离子; n=0、1; m=0、1、2; p=1、2、3; q=2、3、4; r=0、1;以及它们的酸或碱的药学上可接受的盐; 在通式II的每个分子中不超过一个取代基R.sup.9。这些新的衍
生物可用于药物治疗。